Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI
Expert Review of Pharmacoeconomics & Outcomes Research · 09.08.2026 · 26 (7) · 861-871
DOI: 10.1080/14737167.2026.2694563 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, online erschienen am 22.07.2026. Verfasst von Mehdi Khakian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Fertilization in Vitro, Infertility, Reproductive Techniques, Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: School of Health Management and Information Sciences, Iran University of Medical Sciences.
Abstract (Originalsprache)
INTRODUCTION: Couples suffering from infertility range between 10 and 15% worldwide. As assisted reproductive technologies revolutionize treatment, this systematic review synthesizes economic evaluations of these ART methods to identify cost-effective ones. METHODS: A search of the PubMed, Embase, Web of Science, Scopus databases and Google Scholar was conducted from 1990 to 2024 to find full economic analyses studies of IVF, IUI, and ICSI. Comparing at least two ART methods for infertile couples or strategies within amethod is one of the incl usion criteria. Qualitative descriptions and summaries provided concerning the cost-effectiveness of all interventions. A comprehensive narrative synthesis of the data developed. This categorized based on the type of intervention. RESULTS: A total of 102 studies were included, mostly from CEAs. In cases of poor prognosis, IVF is the most cost-effective treatment option, while IUI is the most cost-effective in cases of mild prognosis. While ICSI is not recommended routinely for non-male factor infertility, it is an effective treatment for severe male factor infertility. Age and etiology were identified as key factors influencing the cost-effectiveness results. CONCLUSION: Prognosis-based strategies (such as IUI first for mild cases, selective ICSI) are more cost effective. REGISTRATION: PROSPERO (CRD420251242666).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
- Department of Health Services and Health Promotion, School of Health, Occupational Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
- Department of Obstetrics and Gynecology, Infertility Fellowship, Iran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mehdi Khakian, Aghdas Souresrafil, Farahnaz Farzaneh, Aziz Rezapour
Förderung
- School of Health Management and Information Sciences, Iran University of Medical Sciences
Zitieren
APA
Khakian, M., Souresrafil, A., Farzaneh, F., & Rezapour, A. (2026). Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI. Expert Review of Pharmacoeconomics & Outcomes Research, 26(7), 861-871. https://doi.org/10.1080/14737167.2026.2694563
Vancouver
Khakian M, Souresrafil A, Farzaneh F, Rezapour A. Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI. Expert Review of Pharmacoeconomics & Outcomes Research. 2026;26(7):861-871. doi:10.1080/14737167.2026.2694563
BibTeX
@article{Khakian2026,
author = {Khakian, Mehdi and Souresrafil, Aghdas and Farzaneh, Farahnaz and Rezapour, Aziz},
title = {Economic evaluations of assisted reproductive technologies (ART) for specialized infertility treatment: a systematic review of IVF, IUI and ICSI},
journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
year = {2026},
volume = {26},
number = {7},
pages = {861--871},
doi = {10.1080/14737167.2026.2694563}
}
EUVIMED